Effects of oxytocin and antagonist antidote atosiban on body weight and food intake of female mice, Mus musculus

Growing evidence suggests that oxytocin (OT) plays an important factor for the control of food intake, body weight, and energy metabolism in human and non-human animals. It has reported previously, the downregulation in oxytocin receptors (OTRs) expression is linked with the development of obesity,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pratibha Thakur, Renu Shrivastava, Vinoy K. Shrivastava
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/142a0c3f04944cd49378f4e9d96de9ec
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:142a0c3f04944cd49378f4e9d96de9ec
record_format dspace
spelling oai:doaj.org-article:142a0c3f04944cd49378f4e9d96de9ec2021-11-12T04:46:23ZEffects of oxytocin and antagonist antidote atosiban on body weight and food intake of female mice, Mus musculus2589-936810.1016/j.metop.2021.100146https://doaj.org/article/142a0c3f04944cd49378f4e9d96de9ec2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2589936821000700https://doaj.org/toc/2589-9368Growing evidence suggests that oxytocin (OT) plays an important factor for the control of food intake, body weight, and energy metabolism in human and non-human animals. It has reported previously, the downregulation in oxytocin receptors (OTRs) expression is linked with the development of obesity, but exogenous OT reverse body weight and food intake in obese animal model. It is important to know that, whether intraperitoneal administration crosses blood brain barrier. Therefore, in the present experiment, we study the impact of intraperitoneal administration of synthetic OT 0.0116 mg/kg and antagonist atosiban (OTA) 1 mg/kg on food intake, and body weight of female mice, Mus musculus for different duration i.e. 30, 60, and 90 days. In this study, it was observed that there was significant decrease (p<0.001, one-way analysis of variance [ANOVA]) in the body weight (BW), food intake, and gonadosmatic indices (GSI) after the intraperitoneal exposure of OT at dose 0.0116 mg/kg up to 90 days and inhibits via antagonist atosiban. These results indicates that intraperitoneal administration of OT can be used for treatment for longer duration without any side effects and maintains homeostasis in physiologic system regulates body weight and gonadal weight in female mice, which represent an important therapeutic tool for the obesity and metabolic disorder in female.Pratibha ThakurRenu ShrivastavaVinoy K. ShrivastavaElsevierarticleOxytocinBody weightFood intakeGonadosomatic indicesEnergy metabolismPhysiologyQP1-981BiochemistryQD415-436ENMetabolism Open, Vol 12, Iss , Pp 100146- (2021)
institution DOAJ
collection DOAJ
language EN
topic Oxytocin
Body weight
Food intake
Gonadosomatic indices
Energy metabolism
Physiology
QP1-981
Biochemistry
QD415-436
spellingShingle Oxytocin
Body weight
Food intake
Gonadosomatic indices
Energy metabolism
Physiology
QP1-981
Biochemistry
QD415-436
Pratibha Thakur
Renu Shrivastava
Vinoy K. Shrivastava
Effects of oxytocin and antagonist antidote atosiban on body weight and food intake of female mice, Mus musculus
description Growing evidence suggests that oxytocin (OT) plays an important factor for the control of food intake, body weight, and energy metabolism in human and non-human animals. It has reported previously, the downregulation in oxytocin receptors (OTRs) expression is linked with the development of obesity, but exogenous OT reverse body weight and food intake in obese animal model. It is important to know that, whether intraperitoneal administration crosses blood brain barrier. Therefore, in the present experiment, we study the impact of intraperitoneal administration of synthetic OT 0.0116 mg/kg and antagonist atosiban (OTA) 1 mg/kg on food intake, and body weight of female mice, Mus musculus for different duration i.e. 30, 60, and 90 days. In this study, it was observed that there was significant decrease (p<0.001, one-way analysis of variance [ANOVA]) in the body weight (BW), food intake, and gonadosmatic indices (GSI) after the intraperitoneal exposure of OT at dose 0.0116 mg/kg up to 90 days and inhibits via antagonist atosiban. These results indicates that intraperitoneal administration of OT can be used for treatment for longer duration without any side effects and maintains homeostasis in physiologic system regulates body weight and gonadal weight in female mice, which represent an important therapeutic tool for the obesity and metabolic disorder in female.
format article
author Pratibha Thakur
Renu Shrivastava
Vinoy K. Shrivastava
author_facet Pratibha Thakur
Renu Shrivastava
Vinoy K. Shrivastava
author_sort Pratibha Thakur
title Effects of oxytocin and antagonist antidote atosiban on body weight and food intake of female mice, Mus musculus
title_short Effects of oxytocin and antagonist antidote atosiban on body weight and food intake of female mice, Mus musculus
title_full Effects of oxytocin and antagonist antidote atosiban on body weight and food intake of female mice, Mus musculus
title_fullStr Effects of oxytocin and antagonist antidote atosiban on body weight and food intake of female mice, Mus musculus
title_full_unstemmed Effects of oxytocin and antagonist antidote atosiban on body weight and food intake of female mice, Mus musculus
title_sort effects of oxytocin and antagonist antidote atosiban on body weight and food intake of female mice, mus musculus
publisher Elsevier
publishDate 2021
url https://doaj.org/article/142a0c3f04944cd49378f4e9d96de9ec
work_keys_str_mv AT pratibhathakur effectsofoxytocinandantagonistantidoteatosibanonbodyweightandfoodintakeoffemalemicemusmusculus
AT renushrivastava effectsofoxytocinandantagonistantidoteatosibanonbodyweightandfoodintakeoffemalemicemusmusculus
AT vinoykshrivastava effectsofoxytocinandantagonistantidoteatosibanonbodyweightandfoodintakeoffemalemicemusmusculus
_version_ 1718431213537984512